What if the conversation around Ozempic and heart health is missing some important pieces?
New FDA reviews and emerging research are putting the spotlight on GLP-1 medications and their potential cardiovascular benefits—but what does the evidence really show, and what questions still need answers?
In this episode of Accelerated Health with Sara Banta, I take a closer look at the growing claims surrounding Ozempic, heart health, cardiovascular risk, and metabolic health. I break down what the latest evidence suggests, what may be getting overlooked, and why looking beyond a single medication could be critical when it comes to protecting your heart.
The headlines may make it sound simple—but your heart health is anything but.
Listen until the end to understand the bigger picture and what you should know before accepting the latest claims at face value.
🎙️Tune in to Accelerated Health with Sara Banta on Monday, Wednesday and Friday on Apple Podcasts, Spotify, iHeartRadio, YouTube Music, Amazon Music, Pandora, Audible, Roku, Amazon, and over 100 other podcast outlets. https://link.chtbl.com/U2_CMchk
📺 You can watch the episodes on YouTube and e360tv.
Podden och tillhörande omslagsbild på den här sidan tillhör
Sara Banta. Innehållet i podden är skapat av Sara Banta och inte av,
eller tillsammans med, Poddtoppen.